Foradil Aerolizer (formoterol fumarate inhalation powder)

What is Foradil Aerolizer?

Foradil Aerolizer (formoterol fumarate inhalation powder) is an inhaled medicine that was previously used to treat symptoms of chronic obstructive pulmonary disease (COPD).1,2 It was discontinued in late 2015. It’s reported that the discontinuation was due to a business decision by the manufacturer, and not due to any efficacy or safety concerns.

Foradil Aerolizer is a type of long-acting beta-agonist bronchodilator medication.1 These are called “LABAs” for short, and are used as “maintenance” drugs for people with COPD. This means that they are taken on a daily basis to help control a patient’s everyday COPD symptoms. Foradil Aerolizer and other LABAs cannot be used as a “rescue” inhaler to treat COPD flare-ups or symptoms that suddenly get worse.

Written by: Kristine Zerkowski | Last reviewed: March 2018.
View References
  1. Foradil Aerolizer [Prescribing Information]. Whitehouse Station, NJ: Merck & Co., Inc.; Revised November 2012.
  2. US Food and Drug Administration. Current and Resolved Drug Shortages and Discontinuations Reported to FDA. Formoterol Fumarate (FORADIL® AEROLIZER®) Inhalation Powder. Accessed March 2018.